Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
コンセンサス評価1
Overweight
最高目標株価1
$435.00
最低目標株価1
$358.00
コンセンサス目標株価1
$392.17
Acuity Inc のコンセンサス目標株価は $392.17 で、6 人のアナリストの評価に基づいています。最高値は $435(10 2, 2025 に Oppenheimer が発表)、最安値は $358(6 26, 2026 に Goldman Sachs が発表)です。直近のアナリスト評価 3 件は Morgan Stanley、Goldman Sachs、Baird により 7 1, 2026、6 26, 2026、6 26, 2026 に発表されました。Morgan Stanley、Goldman Sachs、Baird の平均目標株価は $386 で、これらの最新評価から Acuity Inc に対して 14.68% のupsideが示唆されています。
1アナリスト評価から算出
Acuityの最新目標株価Acuity。(NYSE:AYI) の最新目標株価をMorgan Stanleyが7 1, 2026日に発表した。このアナリスト会社はAcuity (NYSE:AYI) からriseまで12ヶ月以内 (21.81% upsideの可能性あり) と予想する$410.00の目標株価を設定しました。過去1年間に15のアナリスト会社がレーティングを報告しています。
Acuityの最新のアナリストレーティングはAcuityです。(NYSE:AYI) の最新のアナリストレーティングはMorgan Stanleyによるもので、AcuityのAcuityです。維持のoverweight評価です。
Acuity Incの最後のアップグレードは9 2, 2025日に行われ、Wells Fargoは目標株価を$380に引き上げました。Acuity IncのWells Fargoの以前のan equal-weightは$380でした。
Acuity Incの最後の格下げは6 28, 2024日にWells FargoがAcuity Incの目標株価を$295から$260に変更した時です。
アナリストは、公開財務諸表を調べたり、Acuityの役員や顧客に話を聞いたり、決算の電話会議を傍聴したりと、広範な調査を行った上で株価の格付けを行っています。ほとんどのアナリストは3ヶ月ごとにこの作業を行いますので、毎年1社につき4つの格付けを得ることになります。Acuityの最終レーティングは7 1, 2026日に提出されましたので、次のレーティングは7 1, 2027日あたりに提出されるものと思われます。
レーティングは主観的なものであり変化しますが、最新のAcuity (AYI) のレーティングは維持で、目標株価は$400.00から$410.00でした。現在の価格 Acuity (AYI) の現在の取引価格は$336.59で、これはアナリストの予測レンジout ofです。
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Buy Now | Get Alert | ||||||
|---|---|---|---|---|---|---|---|
| 07/01/2026 | Buy Now | 21.81% | Morgan Stanley | $400 → $410 | Maintains | Overweight | Get Alert |
| 06/26/2026 | Buy Now | 6.36% | Goldman Sachs | $295 → $358 | Maintains | Neutral | Get Alert |
| 06/26/2026 | Buy Now | 15.87% | Baird | $315 → $390 | Maintains | Neutral | Get Alert |
| 04/06/2026 | Buy Now | -12.36% | Goldman Sachs | $342 → $295 | Maintains | Neutral | Get Alert |
| 04/06/2026 | Buy Now | -6.41% | Baird | $320 → $315 | Maintains | Neutral | Get Alert |
| 03/25/2026 | Buy Now | -4.93% | Baird | $375 → $320 | Maintains | Neutral | Get Alert |
| 03/03/2026 | Buy Now | 9.93% | Wells Fargo | $385 → $370 | Maintains | Overweight | Get Alert |
| 01/12/2026 | Buy Now | 21.81% | Morgan Stanley | $425 → $410 | Maintains | Overweight | Get Alert |
| 10/02/2025 | Buy Now | 26.27% | Morgan Stanley | $365 → $425 | Maintains | Overweight | Get Alert |
| 10/02/2025 | Buy Now | 5.77% | Goldman Sachs | $312 → $356 | Maintains | Neutral | Get Alert |
| 10/02/2025 | Buy Now | 20.32% | Wells Fargo | $380 → $405 | Maintains | Overweight | Get Alert |
| 10/02/2025 | Buy Now | 15.87% | TD Cowen | $330 → $390 | Maintains | Buy | Get Alert |
| 10/02/2025 | Buy Now | 29.24% | Oppenheimer | $380 → $435 | Maintains | Outperform | Get Alert |
| 09/25/2025 | Buy Now | 6.96% | Baird | $335 → $360 | Maintains | Neutral | Get Alert |
| 09/02/2025 | Buy Now | 12.9% | Wells Fargo | $320 → $380 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 06/27/2025 | Buy Now | 8.44% | Morgan Stanley | $335 → $365 | Maintains | Overweight | Get Alert |
| 06/27/2025 | Buy Now | -0.47% | Baird | $315 → $335 | Maintains | Neutral | Get Alert |
| 06/27/2025 | Buy Now | -4.93% | Wells Fargo | $285 → $320 | Maintains | Equal-Weight | Get Alert |
| 06/18/2025 | Buy Now | -6.41% | Baird | $295 → $315 | Maintains | Neutral | Get Alert |
| 06/17/2025 | Buy Now | -15.33% | Wells Fargo | $275 → $285 | Maintains | Equal-Weight | Get Alert |
| 04/04/2025 | Buy Now | -18.3% | Wells Fargo | $290 → $275 | Maintains | Equal-Weight | Get Alert |
| 04/04/2025 | Buy Now | -12.36% | Baird | $310 → $295 | Maintains | Neutral | Get Alert |
| 03/28/2025 | Buy Now | -13.84% | Wells Fargo | $336 → $290 | Maintains | Equal-Weight | Get Alert |
| 03/27/2025 | Buy Now | -7.9% | Baird | $340 → $310 | Maintains | Neutral | Get Alert |
| 01/09/2025 | Buy Now | 12.9% | Oppenheimer | $370 → $380 | Maintains | Outperform | Get Alert |
| 01/09/2025 | Buy Now | -0.18% | Wells Fargo | $320 → $336 | Maintains | Equal-Weight | Get Alert |
| 01/07/2025 | Buy Now | -4.93% | Wells Fargo | $330 → $320 | Maintains | Equal-Weight | Get Alert |
| 10/02/2024 | Buy Now | -9.98% | Goldman Sachs | $266 → $303 | Maintains | Neutral | Get Alert |
| 10/02/2024 | Buy Now | -9.39% | Wells Fargo | $289 → $305 | Maintains | Equal-Weight | Get Alert |
| 10/02/2024 | Buy Now | 9.93% | Oppenheimer | $315 → $370 | Maintains | Outperform | Get Alert |
| 10/02/2024 | Buy Now | -5.52% | Baird | $280 → $318 | Maintains | Neutral | Get Alert |
| 09/24/2024 | Buy Now | -14.14% | Wells Fargo | $260 → $289 | Maintains | Equal-Weight | Get Alert |
| 06/28/2024 | Buy Now | -22.75% | Wells Fargo | $295 → $260 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 06/18/2024 | Buy Now | -16.81% | Baird | $286 → $280 | Maintains | Neutral | Get Alert |
| 04/04/2024 | Buy Now | -22.46% | Goldman Sachs | $227 → $261 | Maintains | Neutral | Get Alert |
| 04/04/2024 | Buy Now | -6.41% | Oppenheimer | $250 → $315 | Maintains | Outperform | Get Alert |
| 04/04/2024 | Buy Now | -12.36% | Wells Fargo | $260 → $295 | Maintains | Overweight | Get Alert |
| 03/26/2024 | Buy Now | -15.03% | Baird | $236 → $286 | Maintains | Neutral | Get Alert |
| 12/19/2023 | Buy Now | -29.89% | Wells Fargo | $200 → $236 | Maintains | Overweight | Get Alert |
| 09/21/2023 | Buy Now | -49.49% | Baird | $175 → $170 | Maintains | Neutral | Get Alert |